Klinik Atölye

Lenfatik sistem ve dalak · Patoloji · Orta öncelik

Splenik marjinal zon lenfoması

Splenic marginal zone lymphoma

Eğitim amaçlıdır; hasta başında tanı ve tedavi kararının yerine geçmez.

Splenik marjinal zon lenfoması: yayımlanmış olgu görüntüsü, aksiyel kesit

4 adım

Görüntü: Zhang S, Xuan Z, Zhang L ve ark., “Splenic marginal zone lymphoma: a case report and literature review.” 2020, Fig. 1. PMC7532117 · doi:10.1186/s12957-020-02030-3 · CC BY 4.0. Değişiklik: kırpıldı, yeniden boyutlandırıldı, odak işaretleri eklendi.

Özet

Splenik marjinal zon lenfoması genellikle 50 yaşından sonra görülen, indolent seyirli bir B hücreli lenfomadır ve çoğunlukla belirgin splenomegaliyle ortaya çıkar. BT, dalak boyutunu ve odaklarını haritalar; özellikle splenik hilus dışındaki nodal ya da ekstranodal yayılımı arayarak evreleme değerlendirmesine katkı verir. Dalakta belirgin büyüme olmasına karşın parankim homojen kalabileceğinden, normal görünümlü parankim hastalığı dışlamaz. Fokal lezyonları enfeksiyon veya infarkta bağlamak, yayılımı ve olası komplikasyonları gözden kaçırabilir.

Faz ve pencere

Portal tanısal
Normal dalak portal venöz fazda homojen kontrastlanır; SMZL çoğunlukla fokal kitle yerine diffüz splenomegaliyle ortaya çıkar. Daha seyrek olarak hipoattenüe odaklar seçilir; aynı faz hiler nodları ve karın içi yayılımı karşılaştırmaya elverişlidir.

Önerilen pencereler: Batın (G 400 / M 50), Yumuşak doku (G 400 / M 40).

BT bulguları

  • Dalak uzun ekseni ve hacminde artış; infiltrasyon diffüz ise belirgin sınırlı kitle olmayabilir.
  • Dalakta fokal lezyon görülmemesi splenik lenfomayı dışlamaz; lenfoma splenomegaliyle birlikte odaksız görünebilir.
  • SMZL çoğunlukla diffüz splenomegaliyle ortaya çıkar; nadiren fokal splenik kitle şeklinde de görülebilir.
  • Splenik hilus çevresindeki lenf nodlarını, splenik lenfomaya eşlik edebilen bir bulgu olarak incele.
  • Hiler bölge dışındaki abdominal nodal istasyonlar ve karaciğer büyümesi eşlik edebilir.
  • BT bulguları SMZL'yi tek başına doğrulamaz; klinik, kan ve doku incelemesiyle birlikte yorumlanır.

Ölçütler ve sınıflamalar

WHO-HAEM5 histolojik sınıflaması
Splenik marjinal zon lenfoması WHO-HAEM5'te splenik B hücreli lenfomalar ve lösemiler başlığı altında ayrı bir antite olarak yer alır; görüntüleme tanıyı tek başına kesinleştirmez.

Normalde

Normal dalak portal venöz BT'de homojen atenuasyon gösterir; dalak boyutu ve şekli değişkenlik gösterebilir, şekli komşu organlardan etkilenir. Dalak boyutu ve şekli değişkenlik gösterir; splenik lenfoma odaksız splenomegali şeklinde görülebilir. Dalak boyutunun normal olup olmadığını belirlemek güç olabilir; aksiyel ölçüler için önerilmiş referanslar bulunsa da tek bir çapı kesin eşik olarak yorumlama.

Normal BT ile kıyasla

Aynı bölgenin, kaynak veri setinde patoloji içermediği belirtilen bir BT incelemesini kesit kesit kaydırın; organ sınırlarını açarak anatomiyi hasta görüntüsüyle karşılaştırın. Küçük rastlantısal bulgular tümüyle dışlanmamıştır.

Kaynak: TotalSegmentator v2.01 veri seti (Wasserthal ve ark., Radiology: Artificial Intelligence 2023), CC BY 4.0, vaka s0541; organ sınırları veri setinin otomatik segmentasyonundan, birleştirilerek sadeleştirildi. Görüntüler 2,5 mm kesit aralığına yeniden örneklendi.

Ayırıcı tanı

Dalak diffüz büyük B hücreli lenfoması
daha sık kitle oluşturan veya belirgin fokal infiltratif görünüm ve hızlı klinik gidişle ayrılır.
KLL'de splenomegali ve sitopeni görülebilir; lenfositoz ve lenfadenopati de klinik tabloya eşlik edebilir.
Splenik sarkoidoz
hiler nodlarla birliktelik olabilir; akciğer ve karaciğer bulguları destekleyebilir.
Fungal dalak apseleri çoğunlukla çok odaklıdır, 2 cm'den küçüktür ve kontrastlı BT'de çevresel kontrastlanma göstermez.
Splenik infarkt
periferik, kama biçimli ve kapsüle taban veren perfüzyon kusuru beklenir.

Tuzaklar

  • Splenik hilusta lenfadenopati splenik lenfomayı destekleyebilir ancak özgül değildir; splenik lenfomada lenfadenopati bulunmayabilir de.
  • Dalak arteriyel fazda fizyolojik olarak trabeküler veya yılanımsı heterojen kontrastlanabilir; portal venöz fazda ise homojen görünüm beklenir.
  • Homojen dalak görünümünü lenfoma yokluğu olarak raporlama; diffüz infiltrasyon kitle oluşturmadan yalnız splenomegali yapabilir.

Kendini dene

  1. Splenomegalisi olan erişkinde portal fazda parankim neredeyse homojen; hiler nodlar mevcut. Hangi tanı olasılıklardan biridir?

    Cevabı göster

    Splenik marjinal zon lenfoması. SMZL dalakta kitle yapmadan büyümeye neden olabilir ve hiler nodlar eşlik edebilir. İnfarkt kama biçimli perfüzyon kaybı, apse sıvı koleksiyonu, hemanjiyom ise vasküler odak paterni bekletir; BT alt tipi kesinleştirmez.

  2. SMZL'nin tipik dalak görüntüleme görünümü hangisidir?

    Cevabı göster

    Diffüz splenomegali ve genellikle fokal kitle olmaması. SMZL tipik olarak fokal splenik kitle yerine diffüz splenomegaliyle görülür. Kapsüle taban veren kama biçimli hipodens alan infarktı düşündürür; fungal dalak apseleri ise çoğunlukla çok odaklıdır, 2 cm'den küçüktür ve çevresel kontrastlanma göstermez.

İlgili konular

Kaynaklar

Bu sayfadaki 37 cümle ve 2 quiz sorusu aşağıdaki kaynaklardan alıntılarla otomatik olarak karşılaştırıldı; 17 cümle bu karşılaştırmada düzeltildi (2026-10-09).

  1. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasmspmc.ncbi.nlm.nih.gov
  2. Computed tomography of the spleen: how to interpret the hypodense lesionpmc.ncbi.nlm.nih.gov
  3. Antiphospholipid antibodies in malignancy: are these pathogenic or epiphenomena?pubmed.ncbi.nlm.nih.gov
  4. Chronic kidney disease linked to SARS-CoV-2 infection: a case report.pubmed.ncbi.nlm.nih.gov
  5. [Splenic marginal zone lymphoma].pubmed.ncbi.nlm.nih.gov
  6. Sarcoidosis-lymphoma syndrome: a diagnostic dilemma.pubmed.ncbi.nlm.nih.gov
  7. Impact of splenectomy on prognosis in lymphoma with splenic involvement.pubmed.ncbi.nlm.nih.gov
  8. Follicular lymphoma presenting with marked splenomegaly: report of three cases.pubmed.ncbi.nlm.nih.gov
  9. 18F-FDG PET/CT in splenic marginal zone lymphoma.pubmed.ncbi.nlm.nih.gov
  10. Successful Surgical Removal of the Largest Known Spleen.pubmed.ncbi.nlm.nih.gov
  11. Splenic Marginal Zone Lymphoma in the Setting of Noncirrhotic Portal Hypertension.pubmed.ncbi.nlm.nih.gov
  12. Splenic marginal zone lymphoma: a case report and literature review.pubmed.ncbi.nlm.nih.gov
  13. Massive splenomegaly requiring differential diagnosis of hematologic malignancies.pubmed.ncbi.nlm.nih.gov
  14. Synchronous rectal adenocarcinoma and splenic marginal zone lymphoma.pubmed.ncbi.nlm.nih.gov
  15. Pediatric presentation of splenic marginal zone lymphoma on FDG PET/CT scan.pubmed.ncbi.nlm.nih.gov
  16. Marginal zone lymphoma presenting with chylous ascites: A rare clinical manifestation and successful treatment with orelabrutinib-rituximab.pubmed.ncbi.nlm.nih.gov
  17. Coexistence of Microscopic Polyangiitis, Systemic Lupus Erythematosus, and Transthyretin Amyloidosis in an Elderly Japanese Patient With Splenic Marginal Zone Lymphoma: An Autopsy Case Report.pubmed.ncbi.nlm.nih.gov
  18. Classic Hairy Cell Leukemia and Related Disorders: An Updated Review of Molecular Features and Personalized Therapies.pubmed.ncbi.nlm.nih.gov
  19. Patterns of injury and violence in Yaoundé Cameroon: an analysis of hospital data.pubmed.ncbi.nlm.nih.gov
  20. Splenic Marginal Zone Lymphoma as a Vascular-Appearing Mass in a Patient With Sustained Virologic Response to Hepatitis C Therapy.pubmed.ncbi.nlm.nih.gov
  21. Multimodality Imaging Features of Various Splenic Lesions: Clinical and Histopathologic Correlation.pubmed.ncbi.nlm.nih.gov
  22. Machine Learning Radiomics Signature for Differentiating Lymphoma versus Benign Splenomegaly on CT.pubmed.ncbi.nlm.nih.gov
  23. Typical and Atypical Imaging Features of Malignant Lymphoma in the Abdomen and Mimicking Diseases.pubmed.ncbi.nlm.nih.gov
  24. A Recently Recognized and Underdiagnosed Entity of Splenic Diffuse Red Pulp Small B-Cell Lymphoma: A Report of Two Cases.pubmed.ncbi.nlm.nih.gov
  25. Case Report: Diagnosis of splenic marginal zone lymphoma by ultrasound and contrast- enhanced ultrasound.pubmed.ncbi.nlm.nih.gov
  26. Different facets of intracranial central nervous system lymphoma and its imaging mimics.pubmed.ncbi.nlm.nih.gov
  27. Special Issue: EACR 2026 Congress: Innovative Cancer Science, 8-11 June 2026.pubmed.ncbi.nlm.nih.gov
  28. Radiologic and pathologic correlation of anterior mediastinal lesions.pubmed.ncbi.nlm.nih.gov
  29. Long-term safety and effectiveness of the "OptEase" vena cava filter.pubmed.ncbi.nlm.nih.gov
  30. Management of marginal zone lymphomas.pubmed.ncbi.nlm.nih.gov
  31. Hairy cell leukemia in a 51-year-old Syrian male: a case report.pubmed.ncbi.nlm.nih.gov
  32. Unicentric Castleman disease of plasma cell type in the adrenal region: a case report and literature review.pubmed.ncbi.nlm.nih.gov
  33. <sup>68</sup>Ga-pentixafor PET pulmonary uptake in patients with suspected primary aldosteronism: incidence and etiology.pubmed.ncbi.nlm.nih.gov
  34. Splenoses and Other Ectopic and Heterotopic Splenic Tissue: The Use of Long-Lasting Enhancement in Contrast-Enhanced Ultrasound to Avoid Unnecessary Intervention.pubmed.ncbi.nlm.nih.gov
  35. Multimodal imaging features to diagnose abdominal complications of sickle cell disease.pubmed.ncbi.nlm.nih.gov
  36. Case Report: A rare case of hemorrhagic cystic IPAS masquerading as pancreatic neoplasm.pubmed.ncbi.nlm.nih.gov
  37. CT, MRI, and FDG PET/CT in the Assessment of Lymph Node Involvement in Pediatric Hodgkin Lymphoma: An Expert Consensus Definition by an International Collaboration on Staging Evaluation and Response Criteria Harmonization for Children, Adolescent, and Young Adult Hodgkin Lymphoma (SEARCH for CAYAHL).pubmed.ncbi.nlm.nih.gov
  38. Tips and Tricks in Thoracic Radiology for Beginners: A Findings-Based Approach.pubmed.ncbi.nlm.nih.gov
  39. CT Findings in Pulmonary and Abdominal Sarcoidosis. Implications for Diagnosis and Classification.pubmed.ncbi.nlm.nih.gov
  40. Comparison of canine adrenal gland size assessment using ultrasonography and computed tomography.pubmed.ncbi.nlm.nih.gov
  41. Establishing selection criteria for male New Zealand white rabbits in interventional radiology research using organ volumes and vessel diameters.pubmed.ncbi.nlm.nih.gov
  42. Time-Dependent Association of Thoracic Anthropometric Parameters with Survival After In-Hospital Cardiac Arrest: A Retrospective Single-Center Observational Study.pubmed.ncbi.nlm.nih.gov
  43. Spectrum of Neuroimaging Findings in CNS Lymphoproliferative Disorders.pubmed.ncbi.nlm.nih.gov
  44. Real-World Application of the WHO Reporting System for Lymph Node Cytopathology in the Context of the 5th Edition of the WHO Classification of Hematolymphoid Neoplasms.pubmed.ncbi.nlm.nih.gov
  45. Comparison of the World Health Organisation and International Consensus Classification of haematolymphoid tumours.pubmed.ncbi.nlm.nih.gov
  46. The rare phenomenon of glomerulonephritis presentation in extra-nodal marginal zone lymphoma: summary of two cases and review of the literature.pubmed.ncbi.nlm.nih.gov
  47. PET-CT in Clinical Adult Oncology: I. Hematologic Malignancies.pubmed.ncbi.nlm.nih.gov
  48. Concurrent hepatic cirrhosis and chronic lymphocytic leukemia: a challenging coexistence: a case report.pubmed.ncbi.nlm.nih.gov
  49. Bruton Tyrosine Kinase Inhibition in Combination With Bispecific Antibodies for Richter's Syndrome: A Report of Two Cases and Mini Review.pubmed.ncbi.nlm.nih.gov
  50. A Diagnostic Challenge in Regional Australia: Concurrent <i>Mycobacterium avium</i> Complex Lymphadenitis and Hairy Cell Leukemia.pubmed.ncbi.nlm.nih.gov
  51. Systemic chronic beryllium disease: beyond lung disease.pubmed.ncbi.nlm.nih.gov
  52. Multisystem FDG-avid sarcoidosis with osseous involvement mimicking disseminated metastatic malignancy.pubmed.ncbi.nlm.nih.gov
  53. Diagnostic Journey to Granulomatosis with Polyangiitis with Rare Hepatic and Suspected Splenic Involvement: A Case Report.pubmed.ncbi.nlm.nih.gov
  54. Hepatic cysts: a survival guide.pubmed.ncbi.nlm.nih.gov
  55. Cross-sectional imaging findings of splenic infections: is differential diagnosis possible?pubmed.ncbi.nlm.nih.gov
  56. Imaging of abdominal and pelvic infections in the cancer patient.pubmed.ncbi.nlm.nih.gov
  57. Adult Hepatic Infarction for Internists: A Practical Diagnostic and Management Pathway to Avoid Misdiagnosis, Unnecessary Drainage, and Delayed Vascular Recognition.pubmed.ncbi.nlm.nih.gov
  58. Infarcts and ischemia in the abdomen: an imaging perspective with an emphasis on cross-sectional imaging findings.pubmed.ncbi.nlm.nih.gov
  59. Contrast-enhanced ultrasound performed under urgent conditions. Indications, review of the technique, clinical examples and limitations.pubmed.ncbi.nlm.nih.gov
  60. The Spectrum of Solitary Benign Splenic Lesions-Imaging Clues for a Noninvasive Diagnosis.pubmed.ncbi.nlm.nih.gov
  61. Liver: glucose metabolism and 18F-fluorodeoxyglucose PET findings in normal parenchyma and diseases.pubmed.ncbi.nlm.nih.gov
  62. Dual-Energy CT Images: Pearls and Pitfalls.pubmed.ncbi.nlm.nih.gov
  63. Clinicopathological Pearls and Diagnostic Pitfalls in IgG4-Related Disease: Challenging Case Series and Literature Review.pubmed.ncbi.nlm.nih.gov
  64. Recommendations for the Management of Patients with Hairy-Cell Leukemia and Hairy-Cell Leukemia-like Disorders: A Work by French-Speaking Experts and French Innovative Leukemia Organization (FILO) Group.pubmed.ncbi.nlm.nih.gov
  65. Imaging and pathological characteristics of hepatosplenic EBV-positive inflammatory follicular dendritic cell sarcoma.pubmed.ncbi.nlm.nih.gov
  66. The Blood Supply of the Stomach: Anatomical and Surgical Considerations.pubmed.ncbi.nlm.nih.gov
  67. DescriptorMedSAM: language-image fusion with multi-aspect text guidance for medical image segmentation.pubmed.ncbi.nlm.nih.gov
  68. Efficacy of an Abdominal Surgery Simulator in Didactic Medical Training: A Randomized Controlled Trial.pubmed.ncbi.nlm.nih.gov
  69. International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Non-proliferative and Proliferative Lesions of the Non-human Primate ( M. fascicularis ).pubmed.ncbi.nlm.nih.gov
  70. Tumours of the spleen.pubmed.ncbi.nlm.nih.gov
  71. Postoperative recurrence patterns and anatomy-stratified clinical target volume delineation in pancreatic cancer.pubmed.ncbi.nlm.nih.gov
  72. An update on pancreatic cancer imaging, staging, and use of the PACT-UK radiology template pre- and post-neoadjuvant treatment.pubmed.ncbi.nlm.nih.gov
  73. The Landmark Series: Minimally Invasive Pancreatic Resection for Ductal Adenocarcinoma, Updates, Trends, and Future Considerations.pubmed.ncbi.nlm.nih.gov
  74. Complications of lymphoma in the abdomen and pelvis: clinical and imaging review.pubmed.ncbi.nlm.nih.gov
  75. Splenic marginal zone lymphoma: a literature review of diagnostic and therapeutic challenges.pubmed.ncbi.nlm.nih.gov
  76. Case Report: Rare spontaneous hepatic rupture hemorrhage complicated by autoimmune liver disease.pubmed.ncbi.nlm.nih.gov
  77. A comprehensive update of extracutaneous involvement of mycosis fungoides: A narrative review of literature.pubmed.ncbi.nlm.nih.gov
  78. Malignancy in mirror image anatomy reveals situs inversus totalis as an anatomic modifier of oncologic care.pubmed.ncbi.nlm.nih.gov
  79. Tumor-Induced Rewiring of Splenic Niches: from Immune Organ to Cancer Accomplice.pubmed.ncbi.nlm.nih.gov
  80. The Diagnostic Dilemma of Splenic Non-Hodgkin's Lymphoma and Splenic Abscess: A Narrative Review.pubmed.ncbi.nlm.nih.gov
  81. Commentary: an eye on PET quantification.pubmed.ncbi.nlm.nih.gov
  82. Acquired Hemophilia A Revealing Occult Splenic Marginal Zone Lymphoma.pubmed.ncbi.nlm.nih.gov
  83. Wandering Lymphoma: A Case of Wandering Spleen Secondary to Splenic Marginal Zone Lymphoma.pubmed.ncbi.nlm.nih.gov
  84. A hidden clue behind angioedema in an elderly patient.pubmed.ncbi.nlm.nih.gov
  85. Primary Spinal Marginal Zone Lymphoma Presenting With Spinal Cord Compression: A Case Report.pubmed.ncbi.nlm.nih.gov
  86. Clinical relevance of the compartments and lymphocyte subsets in the human spleen.pubmed.ncbi.nlm.nih.gov
  87. Gastric plasmacytoma with loss of Cd138 expression mimicking extranodal marginal zone lymphoma of mucosa-associated lymphoid tissue: a case report.pubmed.ncbi.nlm.nih.gov
  88. Clonal B-Cell Lymphocytosis of Marginal Zone Origin: Presenting Features, Clinical Evolution and Prognostic Factors.pubmed.ncbi.nlm.nih.gov
  89. Macrophage heterogeneity in human secondary lymphoid organs.pubmed.ncbi.nlm.nih.gov
  90. Persistent Pyelonephritis and Renal Abscess due to <i>Mycoplasma hominis</i> in an Immunocompromised Patient: A Case Report.pubmed.ncbi.nlm.nih.gov
  91. Multimodality imaging of renal lymphoma and its mimics.pubmed.ncbi.nlm.nih.gov
  92. Atraumatic Splenic Rupture as the Initial Manifestation of Splenic Marginal Zone Lymphoma: A Case Report.pubmed.ncbi.nlm.nih.gov
  93. <i>Atractylodes chinensis</i> polysaccharides downregulate RHEB to confer splenoprotective effects against aging-associated disorders.pubmed.ncbi.nlm.nih.gov
  94. Splenic FDG PET uptake and CT volume as prognostic biomarkers in diffuse large B cell lymphoma.pubmed.ncbi.nlm.nih.gov
  95. ESR Essentials: imaging of lymphoma-practice recommendations by the European Society of Oncologic Imaging.pubmed.ncbi.nlm.nih.gov
  96. Diagnostic Approach to Pulmonary B-Cell Lymphomas in Small Biopsies, with Practical Recommendations to Avoid Misinterpretation.pubmed.ncbi.nlm.nih.gov
  97. Lymph node metastasis in cancer progression: molecular mechanisms, clinical significance and therapeutic interventions.pubmed.ncbi.nlm.nih.gov
  98. Small B-cell lymphoma highly suspicious for splenic marginal zone lymphoma with <i>MYD88</i> L265P mutation and <i>MYC</i> copy-number gain presenting as severe autoimmune hemolytic anemia: a case report with literature review.pubmed.ncbi.nlm.nih.gov
  99. SPEN Loss Drives Extrafollicular Diffuse Large B-cell Lymphoma with Female-Specific Lethality and Therapeutic Vulnerabilities.pubmed.ncbi.nlm.nih.gov
  100. From CT to Microscopy: Radiological-Histopathological Correlation for Understanding Abdominal Lymphomas.pubmed.ncbi.nlm.nih.gov
  101. Real-world lymphoma cohort in an HIV-endemic setting: cohort design, epidemiological features and impact of implementing novel classification standards.pubmed.ncbi.nlm.nih.gov
  102. Splenic, Nonhairy, B-Cell Lymphoma Presenting as Fever of Unknown Origin.pubmed.ncbi.nlm.nih.gov
  103. Leukemic Non-Nodal Mantle Cell Lymphoma Presenting with Traumatic Splenic Rupture.pubmed.ncbi.nlm.nih.gov
  104. Notch2, a Key Player in Chronic Lymphocytic Leukemia: Mechanism, Microenvironment Interactions, and Therapeutic Implications.pubmed.ncbi.nlm.nih.gov
  105. EBUS-guided Cryobiopsy-Proven Anthracotic Mediastinal Lymph Node Mimicking Malignancy on FDG PET-CT: A Case Report.pubmed.ncbi.nlm.nih.gov
  106. Primary Splenic Follicular Lymphoma Presenting As Isolated Splenomegaly: A Case Report.pubmed.ncbi.nlm.nih.gov
  107. Coombs-Negative Hemolytic Anemia and Thrombocytopenia Associated With Sarcoidosis Confined to the Spleen and Bone Marrow: A Case Report.pubmed.ncbi.nlm.nih.gov
  108. Functional Heterogeneity of Immune Cell Subpopulations in Atherosclerosis: From Basic Mechanisms to Precision Therapy.pubmed.ncbi.nlm.nih.gov
  109. Atlas of gross, histologic, and immunohistologic anatomy of the lymphoid system in Egyptian rousettes (Rousettus aegyptiacus).pubmed.ncbi.nlm.nih.gov

Eğitim amaçlıdır; hasta başında tanı ve tedavi kararının yerine geçmez, tıbbi tavsiye değildir. Metinler yapay zekâ desteğiyle yazıldı ve otomatik bir adımda kaynak alıntılarıyla karşılaştırıldı; bu bir tıbbi doğrulama değildir ve içerik uzman radyolog incelemesinden geçmedi. Klinik kararlarda güncel kılavuzları, kurum protokollerini ve radyoloji raporunu esas alın.